expertreviewby [‘mediPr]

Hong Kong · Sponsored

Cervical Cancer Treatment and Prognosis: Revelations from ESMO 2024 Gynaecological Cancers Congress

16 Sept 2024Oncology

This content is sponsored. It is intended for healthcare professionals only.

Cervical cancer (CC) is the 4th most common cancer in women worldwide, with approximately 660,000 new cases in 2022. In Hong Kong, it was the 7th most common cancer among women in 2021, with approximately 600 new cases and 178 deaths. Here we report new findings on CC treatment and prognostic methods from three abstracts published at the annual ESMO Gynaecological Cancer Congress, 20–22 June 2024, Florence, Italy.

Cervical Cancer Treatment and Prognosis: Revelations from ESMO 2024 Gynaecological Cancers Congress

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.